1 |
PPARG
| [2] Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Thyroid cancer | D00596
D00596
|
Rosiglitazone
| [5] 46 46, 75, 97, 222, 265 |
2 |
PPARG
| [2] Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Thyroid cancer | D00945
D00945
|
Pioglitazone
| [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
3 |
PPARG
| [2] Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Thyroid cancer | D08378
D08378
|
Pioglitazone
| [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
4 |
PPARG
| [2] Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Thyroid cancer | D08491
D08491
|
Rosiglitazone
| [5] 46 46, 75, 97, 222, 265 |
5 |
PPARG
| [2] Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Thyroid cancer | D11256
D11256
|
Seladelpar
| [2] 93 93, 94 |
6 |
PPARG
| [2] Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Thyroid cancer | D11603
D11603
|
Leriglitazone
| [1] 20 20 |
7 |
MAP2K1
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
8 |
MAP2K1
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
9 |
MAP2K1
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
10 |
MAP2K1
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
11 |
MAP2K2
| [6] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
12 |
MAP2K2
| [6] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
13 |
MAP2K2
| [6] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
14 |
MAP2K2
| [6] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
15 |
RET
| [1] Thyroid cancer Thyroid cancer | D06272
D06272
|
Sorafenib
| [2] 34 34, 86 |
16 |
RET
| [1] Thyroid cancer Thyroid cancer | D06402
D06402
|
Sunitinib
| [2] 28 28, 34 |
17 |
RET
| [1] Thyroid cancer Thyroid cancer | D08524
D08524
|
Sorafenib
| [2] 34 34, 86 |
18 |
RET
| [1] Thyroid cancer Thyroid cancer | D08552
D08552
|
Sunitinib
| [2] 28 28, 34 |
19 |
RXRA
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D02754
D02754
|
Acitretin
| [1] 37 37 |
20 |
RXRA
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D02815
D02815
|
Alitretinoin
| [1] 49 49 |
21 |
RXRA
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D03106
D03106
|
Bexarotene
| [2] 13 13, 75 |
22 |
RXRB
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D02754
D02754
|
Acitretin
| [1] 37 37 |
23 |
RXRB
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D02815
D02815
|
Alitretinoin
| [1] 49 49 |
24 |
RXRB
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D03106
D03106
|
Bexarotene
| [2] 13 13, 75 |
25 |
RXRG
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D02754
D02754
|
Acitretin
| [1] 37 37 |
26 |
RXRG
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D02815
D02815
|
Alitretinoin
| [1] 49 49 |
27 |
RXRG
| [3] Thyroid hormone signaling pathway Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer | D03106
D03106
|
Bexarotene
| [2] 13 13, 75 |
28 |
BRAF
| [2] Vascular smooth muscle contraction Vascular smooth muscle contraction, Thyroid cancer | D06272
D06272
|
Sorafenib
| [2] 34 34, 86 |
29 |
BRAF
| [2] Vascular smooth muscle contraction Vascular smooth muscle contraction, Thyroid cancer | D08524
D08524
|
Sorafenib
| [2] 34 34, 86 |
30 |
BRAF
| [2] Vascular smooth muscle contraction Vascular smooth muscle contraction, Thyroid cancer | D10064
D10064
|
Dabrafenib
| [1] 34 34 |